Form 8-K - Current report:
SEC Accession No. 0001437749-20-020186
Filing Date
2020-09-24
Accepted
2020-09-24 17:04:35
Documents
12
Period of Report
2020-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20200923_8k.htm   iXBRL 8-K 36510
2 EXHIBIT 2.1 ex_204908.htm EX-2.1 541989
  Complete submission text file 0001437749-20-020186.txt   815026

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blfs-20200918.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20200918_def.xml EX-101.DEF 11586
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20200918_lab.xml EX-101.LAB 15466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20200918_pre.xml EX-101.PRE 11740
7 EXTRACTED XBRL INSTANCE DOCUMENT bioli20200923_8k_htm.xml XML 2571
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 201195963
SIC: 3845 Electromedical & Electrotherapeutic Apparatus